AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.2 |
Market Cap | 54.21M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.82 |
PE Ratio (ttm) | -1.76 |
Forward PE | n/a |
Analyst | Hold |
Ask | 1.76 |
Volume | 16,203 |
Avg. Volume (20D) | 62,118 |
Open | 1.48 |
Previous Close | 1.49 |
Day's Range | 1.42 - 1.56 |
52-Week Range | 0.97 - 2.80 |
Beta | undefined |
About APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded ...
Analyst Forecast
According to 3 analyst ratings, the average rating for APYX stock is "Hold." The 12-month stock price forecast is $5, which is an increase of 247.22% from the latest price.
Next Earnings Release
Analysts project revenue of $13.02M, reflecting a -11.2% YoY shrinking and earnings per share of -0.16, making a -42.86% decrease YoY.
2 months ago · seekingalpha.com
Apyx Medical Corporation (APYX) Q3 2024 Earnings Call TranscriptApyx Medical Corporation (NASDAQ:APYX ) Q3 2024 Earnings Call Transcript November 8, 2024 8:00 AM ET Company Participants Jeremy Feffer - MD, LifeSci Advisors Stavros Vizirgianakis - Executive Chairma...